Phase 3 Pericarditis Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
PericarditisRecurrent PericarditisPericarditis Acute
Kiniksa Pharmaceuticals International, plc165 enrolled56 locationsNCT07010159
Recruiting
Phase 3
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Recurrent Pericarditis
Cardiol Therapeutics Inc.110 enrolled26 locationsNCT06708299